Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model

International Journal of Impotence Research

Volumn 20, Issue 3, 2008, Pages 307-314

  Dall'Era, J E ^a   Meacham, R B ^a   Mills, J N ^a   Koul, S ^a   Carlsen, S N ^a   Myers, J B ^a   Koul, H K ^a,b,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Diabetic model; Erectile dysfunction; Gene therapy; VEGF

Indexed keywords

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN GREEN FLUORESCENT PROTEIN FUSION PROTEIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; FLUORESCENCE MICROSCOPY; GENE THERAPY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; MALE; NERVE STIMULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PENIS ERECTION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; ERECTILE DYSFUNCTION; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; MALE; PENILE ERECTION; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43649087967     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2008.1     Document Type: Article

References (19)

1. Rogers RS, Graziottin TM, Lin CS, Lue TF. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Imp Res 2003; 15: 26-37.
2. Christ GJ, Day N, Santizo C, Sato Y, Zhao W, Sclafani T et al. Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. Am J Physiol Heart Circ Physiol 2004; 287: H1544-H1553.
3. Melman A, Bar-Chama N, McCullough A, Davies K, Christ G. hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial. Hum Gene Ther 2006; 17: 1165-1176.
4. Chancellor MB, Tirney S, Mattes CE, Tzeng E, Birder LA, Kanai AJ et al. Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. BJU Int 2003; 91: 691-696.
5. Bivalacqua TJ, Usta MF, Champion HC, Adams D, Namara DB, Abdel-Mageed AB et al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 2003; 169: 1911-1917.
6. Shen ZJ, Wang H, Lu YL, Zhou XL, Chen SW, Chen ZD. Gene transfer of vasoactive intestinal polypeptide into the penis improves erectile response in the diabetic rat. BJU Int 2005; 95: 890-894.
7. Gholami SS, Rogers R, Chang J, Ho HC, Grazziottin T, Lin CS et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003; 169: 1577-1581.
8. Magee TR, Ferrini M, Garban HJ, Vernet D, Mitani K, Rajfer J et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002; 67: 20-28.
9. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7301.
10. Lee M, Ryu JK, Oh SM, Lee E, Shin HY, Song SU et al. Water-soluble lipopolymer as a gene carrier to corpus cavernosum. Int J Imp Res 2005; 17: 326-334.
11. Kichler A. Gene transfer with modified polyethylenimines. J Gene Med 2004; 6: S3-S10.
12. Ryu JK, Cho CH, Shin HY, Song SU, Oh SM, Lee M et al. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006; 13: 705-715.
13. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Enokida H, Tsujimura A et al. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol 2005; 173: 318-323.
14. Shirai M, Yamanaka M, Shiina H, Igawa M, Kawakami T, Ishii N et al. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat. Biochem Biophys Res Commun 2006; 341: 755-762.
15. Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313-13316.
16. Nor JE, Christensen J, Mooney DJ, Polverini PJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999; 154: 375-384.
17. Koul S, Johnson T, Meacham RB, Koul HK. Cloning and characterization of VEGF from LnCaP cells, a line of prostate cancer cells, LOCUS AY766116, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=54401694.
18. Dall'Era JE, Koul S, Mills JN, Myers J, Meacham RB, Koul HK. In-vivo transfection of the rat corpus cavernosum using a non-viral, linear polyethylenimine gene delivery system: a novel application (abstract no.; 1004, AUA annual meeting, 2006, Atlanta).
19. Ahn GJ, Sohn YS, Kang KK, Ahn BO, Kwon JW, Kang SK et al. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats. Int J Imp Res 2005; 17: 134-141.